MetaVia Share Price
NASDAQ: MTVA | Micro Cap | HealthcareMetaVia Stock Performance
MetaVia Share Price Today
As of 19 November 2026, MetaVia Inc.'s share price is $1.13. The stock opened at $1.19, compared to its previous close of $1.26. During today's trading session, MetaVia Inc.'s share price traded between $1.18 and $1.19, with an average price of $1.18. Over the past 52 weeks, the stock has recorded a high of $12.68 and a low of $0.57. In terms of performance, MetaVia Inc.'s share price has declined by 59.86% over the last six months and is up 42.14% on a year-on-year basis.
MetaVia Share Price Chart
MetaVia Quarterly Profit & Loss
All figures in USD
MetaVia Annual Profit & Loss
All figures in USD
MetaVia Balance Sheet
All figures in USD Million
MetaVia Cash Flow
All figures in USD Million
Corporate Actions
About MetaVia
MetaVia Inc is a clinical-stage biotechnology company focused on developing treatments for liver-related cardiometabolic diseases. Its product pipeline includes DA-1726, an oxyntomodulin analogue that acts as a dual GLP-1 and glucagon receptor agonist, being developed for metabolic and alcohol-associated liver diseases. The company is also developing vanoglipel (DA-1241), a GPR119 agonist, in combination with resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
MetaVia Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.20 | $1.18 | -1.26% |
Oct 2026 | $1.54 | $1.20 | -23.89% |
Sep 2026 | $1.68 | $1.57 | -7.10% |
Aug 2026 | $1.51 | $1.69 | +19.01% |
Jul 2026 | $1.43 | $1.42 | -0.35% |
Jun 2026 | $2.76 | $1.43 | -49.38% |
May 2026 | $1.46 | $2.81 | +93.47% |
Apr 2026 | $1.23 | $1.46 | +21.25% |
Mar 2026 | $1.53 | $1.20 | -20.53% |
Feb 2026 | $2.53 | $1.51 | -37.86% |
Jan 2026 | $8.55 | $2.43 | -71.45% |
Dec 2025 | $0.77 | $8.51 | +970.44% |